Loading search results
The Psychobiology of Temperament: An fMRI Study
Sponsor study identifier
Secondary identifiers
observational
550
1 country
1
Study Start
November 10, 2003
Actual (reported)Primary Completion
Not reported
Date not reportedStudy Completion
Not reported
Date not reportedThe purpose of this study is to use brain imaging technology to examine brain changes that occur in children when they are exposed to various kinds of emotional tasks and to determine if these changes are related to the child's temperament. Studies suggest that the risk for developing mood and anxiety disorders in preschool children may be linked to differences in temperament. The relationship between temperament and risk or resilience may reflect the influences of brain activity on behavior at different stages of childhood development. Behavioral inhibition and mood or anxiety disorders have been linked to disturbances in the circuitry of several areas in the brain. However, the involvement of this circuitry in temperament remains unclear. This study will use functional magnetic resonance imaging (fMRI) to examine the function of different parts of the brain in children who have previously undergone temperament studies and have had their temperaments classified. Two sets of studies will be performed in the current protocol. A small set of pilot studies will be performed in infants, by staff at the University of Maryland. In terms of the studies among infants, these subjects will initially be contacted by staff at Maryland and then will be seen at the NIH for up to three visits lasting between 4- to 5- hours during the first year of life. These subjects also will undergo visits at the University of Maryland throughout the first year of life. This study will comprise up to four clinic visits. At Visit 1, children and their parents will meet with study staff individually and together for psychiatric interviews. Children will undergo a physical examination, medical history, a urine drug test, and practice in an fMRI simulator. Saliva samples will be collected from the children and tests will be given to assess stage of puberty, temperament, intelligence, feelings, experiences, and behavior. Other visits include fMRI scans of the brain and other tasks.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
Not reported
Date not reportedClick on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
May 12, 2003
Actual (reported)May 13, 2003
Actual (reported)November 10, 2003
Actual (reported)Task performance
Task performance on paradigms used in the scanner or in the clinic
Up to 4 visits, though age 29
fMRI BOLD signal
MRI BOLD signal changes in response to different paradigms testing different processes including threat, reward, social processes, conditioning, and attention
Up to 4 visits, though age 29
Characterized by temperament - no behavioral inhibition
Parents of children enrolled in the study
Characterized by temperament - high/low behavioral inhibition
Community sample
National Institutes of Health Clinical Center
Bethesda, Maryland, 20892, United States
Stohr GM, Harrewijn A, Morales S, Zeytinoglu S, Laky ZE, Khosravi P, Cardinale EM, Lorenzo N, Stoddard J, Pine DS, Fox NA, Brotman MA, Haller SP. Adolescent cognitive control processing is associated with anxiety in young adulthood during the COVID-19 pandemic. Cogn Affect Behav Neurosci. 2025 Oct;25(5):1485-1495. doi: 10.3758/s13415-025-01293-1. Epub 2025 May 19.
Daniel S Pine, M.D.
National Institute of Mental Health (NIMH)
550 participants (actual enrollment reported by the registry).
First Submitted
May 12, 2003
First Posted
May 13, 2003
Study Start
November 10, 2003
Actual (reported)Contact the study team to confirm eligibility.
Last Updated
October 16, 2026
Record last verified: 2026-05-21
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: